Galaxy Health (000813.SZ) released its third quarter report for 2024 on October 30th, announcing that the company achieved revenue of 0.354 billion yuan in the first three quarters, a year-on-year increase of 5.77%; the net income attributable to shareholders of the listed company was 8.0896 million yuan, a year-on-year decrease of 86.82%; the net income attributable to shareholders of the listed company after deducting non-recurring gains and losses was 4.6112 million yuan, a year-on-year increase of 123.13%; and the basic earnings per share were 0.0037 yuan.